Accueil >
Publications >
Methotrexate–Etoposide–Ifosfamide Compared with Doxorubicin–Cisplatin–Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18–25 Years

Methotrexate–Etoposide–Ifosfamide Compared with Doxorubicin–Cisplatin–Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18–25 Years

1 avr. 2020Journal of Adolescent and Young Adult Oncology

DOI : 10.1089/jayao.2019.0085

Auteurs

Perrine Marec-Berard, Valérie Laurence, Bob-Valéry Occean, Isabelle Ray-Coquard, Claude Linassier, Nadège Corradini, Olivier Collard, Loïc Chaigneau, Didier Cupissol, Pierre Kerbrat, Esma Saada-Bouzid, Corinne Delcambre, François Gouin, Cécile Guillemet, Marta Jimenez, Cyril Lervat, Nathalie Gaspar, Marie-Cécile Le Deley, Laurence Brugieres, Sophie Piperno-Neumann